Screener
Boston Scientific BSX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $905M+13.8% | $1.34B+99.3% | $670M+19.2% | $755M+61.3% | $795M+147% | ||
| —— | $351M+8.0% | $365M+4.9% | $342M+11.8% | $336M+8.0% | ||
| —— | $83M+12.2% | $71M+2.9% | $79M+16.2% | $75M+13.6% | ||
| —— | $348M-35.7% | $1.36B-6.3% | $1.34B+34.0% | $1.29B+58.2% | ||
| —— | $177M-5.3% | $351M+26.7% | $181M+1.1% | $157M+1.3% | ||
| —— | $523M+119% | $89M-97.4% | $256M-77.3% | $1.01B+2,002% | ||
| —— | -$591M-18.2% | -$512M+86.2% | -$502M+64.8% | -$1.13B-315% | ||
| —— | -$260M-212% | -$184M-186% | -$104M-1,586% | -$340M-1,517% | ||
| —— | -$504M-261% | $671M+133% | $735M+278% | —— |
FAQ
- Where does Boston Scientific's cash flow data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
